Novo Nordisk CEO Talks Weight Loss Drug Supply

episode

Bloomberg Talks not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Bloomberg Talks

US Representative Nicole Malliotakis (R-NY) Talks Ceasefire Talks, Reconciliation Push 12 min · 10 Apr 2026

CoreWeave CEO Michael Intrator Talks Anthropic Deal 9 min · 10 Apr 2026

World Bank President Talks Strait of Hormuz 11 min · 09 Apr 2026

McCormick CEO Brendan Foley Talks Unilever Deal 9 min · 09 Apr 2026

Claudia Sahm Talks Inflation Duration, Investment and Consumer Spending 7 min · 09 Apr 2026

EU's Top Data Regulator Talks Tech Rules 8 min · 09 Apr 2026

All episodes from Bloomberg Talks →

Report any issue

Source

Recorded02 May 2024

Publisheromnycontent.com ↗

Handlerec:8026994

Show notes

Novo Nordisk is shipping more introductory doses of its blockbuster weight-loss drug Wegovy in the US as it grapples with supply constraints and competition from Eli Lilly & Co. CEO Lars Fruergaard Jorgensen says the company will continue to ramp up supply of its popular weight-loss drug "gradually." He spoke with Bloomberg's Katie Greifeld and Romaine Bostick. See omnystudio.com/listener for privacy information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in